The US Department of Agriculture approved the genetically modified purple tomato to extend its shelf life and boost nutritional quality almost 15 years after its development.
According to biochemist Cathie Martin, she and her colleagues at Norfolk Plant Scientists (NPS) have been experimenting with pigment production in flowering plants for over two decades, and they've spent almost 15 months developing the purple tomato.
The NPS has been focusing on anthocyanins, the antioxidant-rich pigments that give blackberries and blueberries their signature shades.
Domesticated tomatoes already have genes to produce anthocyanins, but they are not 'turned on.' By carefully adding two genes, the tomatoes and juice become a rich source of antioxidants, because purple pigments are made in the whole tomato, not just the skins.
While there are already some purple-skinned tomatoes, their pigments mostly stop at the outer layers and don't accumulate in the fruit itself.
The NPS also emphasized that there is increasing evidence to show that antioxidants work much better when consumed within foods.
The USDA Animal and Plant Health Inspection Service (APHIS) reported that the tomato was modified to alter its color and enhance its nutritional quality, adding that the plant is unlikely to pose an increased plant pest risk compared to other cultivated tomatoes.
Nathan Pumplin, the CEO of NPS' US-based commercial business, said they are optimistic that they can begin limited distribution of purple tomatoes in the US by 2023.


U.S. Vaccine Policy Shifts Under RFK Jr. Create Uncertainty for Pharma and Investors
Boeing Secures New Labor Contract With Former Spirit AeroSystems Employees
FDA Pilot Program Eases Rules for Nicotine Pouch Makers
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
China Home Prices Rise in January as Government Signals Stronger Support for Property Market
Sandisk Stock Soars After Blowout Earnings and AI-Driven Outlook
American Airlines Plans Return to Venezuela Flights After U.S. Lifts Ban
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Japan Election Poll Signals Landslide Win for Sanae Takaichi, Raising Fiscal Policy Concerns
Oil Prices Surge Toward Biggest Monthly Gains in Years Amid Middle East Tensions
UK Employers Plan Moderate Pay Rises as Inflation Pressures Ease but Persist
Indonesia Stocks Face Fragile Sentiment After MSCI Warning and Market Rout
Asian Currencies Hold Firm as Dollar Rebounds on Fed Chair Nomination Hopes
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options 



